Bruker (BRKR) Cost of Revenue (2010 - 2026)

Bruker (BRKR) has reported Cost of Revenue for 17 consecutive years, with $422.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 3.87% year-over-year to $422.5 million; the trailing twelve-month figure through Jun 2026 stood at $1.9 billion (up 5.25% YoY), and the FY2025 full-year result was $1.9 billion, up 8.26% from the prior year.
• Cost of Revenue slipped to $422.5 million in Q2 2026 per BRKR's latest filing, from $443.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $528.0 million in Q4 2025 and bottomed at $288.7 million in Q1 2022.
• Historically, Cost of Revenue has averaged $395.4 million across 5 years, with a median of $413.2 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Cost of Revenue gained 23.85% in 2023, then dropped 3.87% in 2026.
• Over 5 years, Cost of Revenue stood at $342.5 million in 2022, then advanced by 23.85% to $424.2 million in 2023, then gained by 14.64% to $486.3 million in 2024, then increased by 8.57% to $528.0 million in 2025, then declined by 19.98% to $422.5 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $422.5 million, $443.6 million, and $528.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.